Global Mycotoxin Testing Market

1 INTRODUCTION OF GLOBAL MYCOTOXIN TESTINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL MYCOTOXIN TESTINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL MYCOTOXIN TESTINGMARKET, BY TYPE
5.1 Overview
5.2 Patulin
5.3 Aflatoxins
5.4 Ochratoxins
5.5 Fusarium
5.5.1 Fumonisin
5.5.2 Trichothecenes
5.5.3 Zearalenone
5.6 Others

6 GLOBAL MYCOTOXIN TESTING MARKET, BY TECHNOLOGY
6.1 Overview
6.2 High Performance Liquid Chromatography
6.3 LC-MS/GC-MS
6.4 Immunoassay Based
6.5 Others

7 GLOBAL MYCOTOXIN TESTING MARKET, BY FOOD AND FEED TESTED
7.1 Overview
7.2 Food
7.2.1 Dairy Products
7.2.2 Cereals, Grains and Pulses
7.2.3 Processed Food
7.2.4 Nuts, Seeds and Spices
7.2.5 Poultry and Meat
7.2.6 Others
7.3 Feed
7.3.1 Cakes and Oil Meals
7.3.2 Cereals and Cereal By Products
7.3.3 Forage and Silage
7.3.4 Others

8 GLOBAL MYCOTOXIN TESTINGMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL MYCOTOXIN TESTINGMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Bureau Veritas SA
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 ALS Limited
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Symbio Laboratories
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Intertek Group PLC
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Silliker Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Romer Labs Diagnostic GmbH
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Microbac Laboratories Inc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 SGS SA
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Eurofins Scientific SE
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 Asurequality
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports